Organoclick (Sweden) Performance
| ORGC Stock | SEK 2.60 0.06 2.26% |
The company holds a Beta of -0.4, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Organoclick are expected to decrease at a much lower rate. During the bear market, Organoclick is likely to outperform the market. At this point, Organoclick AB has a negative expected return of -0.18%. Please make sure to check Organoclick's treynor ratio, value at risk, and the relationship between the total risk alpha and maximum drawdown , to decide if Organoclick AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Organoclick AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors. ...more
| Begin Period Cash Flow | 32 M | |
| Total Cashflows From Investing Activities | -14.6 M |
Organoclick |
Organoclick Relative Risk vs. Return Landscape
If you would invest 307.00 in Organoclick AB on August 27, 2024 and sell it today you would lose (41.00) from holding Organoclick AB or give up 13.36% of portfolio value over 90 days. Organoclick AB is generating negative expected returns and assumes 2.7335% volatility on return distribution over the 90 days horizon. Simply put, 24% of stocks are less volatile than Organoclick, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Organoclick Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Organoclick's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Organoclick AB, and traders can use it to determine the average amount a Organoclick's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0674
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ORGC |
Estimated Market Risk
| 2.73 actual daily | 24 76% of assets are more volatile |
Expected Return
| -0.18 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Organoclick is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Organoclick by adding Organoclick to a well-diversified portfolio.
Organoclick Fundamentals Growth
Organoclick Stock prices reflect investors' perceptions of the future prospects and financial health of Organoclick, and Organoclick fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Organoclick Stock performance.
| Return On Equity | -0.32 | |||
| Return On Asset | -0.1 | |||
| Profit Margin | (0.32) % | |||
| Operating Margin | (0.27) % | |||
| Current Valuation | 352.06 M | |||
| Shares Outstanding | 97.95 M | |||
| Price To Earning | (17.42) X | |||
| Price To Book | 3.99 X | |||
| Price To Sales | 3.07 X | |||
| Revenue | 110.06 M | |||
| EBITDA | (14.57 M) | |||
| Cash And Equivalents | 34.25 M | |||
| Cash Per Share | 0.11 X | |||
| Total Debt | 24.85 M | |||
| Debt To Equity | 198.40 % | |||
| Book Value Per Share | 0.81 X | |||
| Cash Flow From Operations | (37.69 M) | |||
| Earnings Per Share | (0.33) X | |||
| Total Asset | 188.39 M | |||
| Retained Earnings | (76 M) | |||
| Current Asset | 52 M | |||
| Current Liabilities | 22 M | |||
About Organoclick Performance
Assessing Organoclick's fundamental ratios provides investors with valuable insights into Organoclick's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Organoclick is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
OrganoClick AB develops, produces, and markets functional materials in Sweden. OrganoClick AB was founded in 2006 and is headquartered in Tby, Sweden. OrganoClick operates under Research And Specialist Materials classification in Sweden and is traded on Stockholm Stock Exchange.Things to note about Organoclick AB performance evaluation
Checking the ongoing alerts about Organoclick for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Organoclick AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Organoclick AB generated a negative expected return over the last 90 days | |
| Organoclick AB has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Organoclick AB has accumulated 24.85 M in total debt with debt to equity ratio (D/E) of 198.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Organoclick AB has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Organoclick until it has trouble settling it off, either with new capital or with free cash flow. So, Organoclick's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Organoclick AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Organoclick to invest in growth at high rates of return. When we think about Organoclick's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 110.06 M. Net Loss for the year was (32.69 M) with profit before overhead, payroll, taxes, and interest of 18.51 M. | |
| Organoclick AB has accumulated about 34.25 M in cash with (37.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11. | |
| Roughly 35.0% of Organoclick outstanding shares are owned by corporate insiders |
- Analyzing Organoclick's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Organoclick's stock is overvalued or undervalued compared to its peers.
- Examining Organoclick's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Organoclick's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Organoclick's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Organoclick's stock. These opinions can provide insight into Organoclick's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Organoclick Stock Analysis
When running Organoclick's price analysis, check to measure Organoclick's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organoclick is operating at the current time. Most of Organoclick's value examination focuses on studying past and present price action to predict the probability of Organoclick's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organoclick's price. Additionally, you may evaluate how the addition of Organoclick to your portfolios can decrease your overall portfolio volatility.